Our study enrolled 195 HNSCC patients who received TPF induction chemotherapy and showed that high expression of p16 cytoplasmic staining was a more favorable predictive factor for better response to induction chemotherapy than low expression. Here, CDKN2A is linked to head and neck squamous cell carcinoma.